Screening of Complement Inhibitors: Shielded Baculoviruses Increase the Safety and Efficacy of Gene DeliveryComplement Shielded Baculoviruses

Minna U Kaikkonen1,2, Antti I Maatta1, Seppo Ylä-Herttuala 1,3,4and Kari J Airenne1

Sources: 1 Department of Biotechnology and Molecular Medicine, AI Virtanen Institute, University of Eastern Finland, Kuopio, Finland2 Ark Therapeutics Ltd, Kuopio, Finland 3 Department of Medicine, University of Eastern Finland, Kuopio, Finland4 Gene Therapy Unit, Kuopio University Hospital, Kuopio, Finland

Molecular Therapy , (23 February 2010) | doi:10.1038/mt.2010.25